SEC
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
Illumina shareholders will receive one share of Grail for every six shares of Illumina stock, with cash issued in lieu of fractional shares.
SEC Concludes CareDx Investigation, Recommends No Enforcement Action
The SEC informed CareDx in a letter that it had concluded an investigation into the company's accounting and public reporting practices.
SEC Investigating Illumina Over Grail Acquisition
Illumina said the SEC has requested documents, including records "related to the conduct and compensation of certain members of Illumina and Grail management."
Co-Diagnostics Fined $250K Over COVID-19 Claims, Undisclosed Hiring of Relatives
The firm settled with the US Securities and Exchange Commission without admitting or denying the allegations over public statements and hiring disclosures.
Genomics Firms Tackle Carbon Emissions, Face Obstacles to Net-Zero Goals From Suppliers, Shipping
Premium
Proposed SEC rules about emissions reporting are spurring companies to act, but carbon reductions could be offset by growth and lack of control over the supply chain.